Why would they not have two seperate releases for the NaNose Medical sensor?
The first and earlier release could be to identify Covid-19 only. This would be used by Covid testing stations, airports, businesses, schools etc.
The second release would cover the 17 Diseases eg. lung cancer, prostate cancer etc. and be held by hospitals and medical practices or other specialist people.
If the NaNose release to market is being held up by trials still being conducted in relation to the 17 diseases then push approval of Covid testing through first by itself.
I am sure people would not like to be completing a NaNose test at an airport before flying on holidays and be told by the operator ' sorry about your lung cancer'.
Why would they not have two seperate releases for the NaNose...
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $304.1M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $927.5K | 5.842M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 1597497 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 456481 | 7 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| BRN (ASX) Chart |